TY - JOUR
T1 - Case Report
T2 - Novel combinatorial factors in the WNT pathway in a pediatric case of valvular aortic stenosis from Lebanon: a brief report
AU - Ataya, Wiam
AU - Mohammed, Fathima
AU - Arabi, Mariam
AU - Bitar, Fadi
AU - Nemer, Georges
N1 - Publisher Copyright:
2025 Ataya, Mohammed, Arabi, Bitar and Nemer.
PY - 2025
Y1 - 2025
N2 - Introduction: Aortic stenosis (AS) is a common valvular disease with a complex and incompletely defined genetic architecture. The contribution of inherited factors may be particularly prominent in consanguineous populations, where familial clustering suggests a strong hereditary component. We investigated the genetic basis of AS in a consanguineous Lebanese family. Methods: We performed clinical phenotyping and trio whole-exome sequencing (WES) on a 12-year-old female proband with severe valvular AS and her phenotypically normal consanguineous parents. Variants were assessed with standard filtering for rarity, predicted functional impact, and biological plausibility, with particular attention to genes implicated in cardiovascular development and signaling pathways. Results: The proband presented with severe aortic stenosis, bicuspid aortic valve, dilated aortic root and ascending aorta, and mild -moderate tricuspid regurgitation, requiring multiple interventions (balloon valvuloplasty, Ross procedure, and right ventricle-pulmonary artery conduit replacement). WES identified three heterozygous variants in genes belonging to the Wnt signaling pathway APCDD1, DVL1, and AXIN2 in the proband, which were inherited from the normal parents. Discussion: The co-occurrence of heterozygous variants in Wnt pathway genes in a child with severe AS highlights a potential polygenic or pathway-level contribution to disease susceptibility, even within a consanguineous context. These findings support a role for Wnt signaling in aortic valve development and pathology, motivating further functional studies and broader cohort analyses to clarify pathogenicity, segregation, and clinical relevance.
AB - Introduction: Aortic stenosis (AS) is a common valvular disease with a complex and incompletely defined genetic architecture. The contribution of inherited factors may be particularly prominent in consanguineous populations, where familial clustering suggests a strong hereditary component. We investigated the genetic basis of AS in a consanguineous Lebanese family. Methods: We performed clinical phenotyping and trio whole-exome sequencing (WES) on a 12-year-old female proband with severe valvular AS and her phenotypically normal consanguineous parents. Variants were assessed with standard filtering for rarity, predicted functional impact, and biological plausibility, with particular attention to genes implicated in cardiovascular development and signaling pathways. Results: The proband presented with severe aortic stenosis, bicuspid aortic valve, dilated aortic root and ascending aorta, and mild -moderate tricuspid regurgitation, requiring multiple interventions (balloon valvuloplasty, Ross procedure, and right ventricle-pulmonary artery conduit replacement). WES identified three heterozygous variants in genes belonging to the Wnt signaling pathway APCDD1, DVL1, and AXIN2 in the proband, which were inherited from the normal parents. Discussion: The co-occurrence of heterozygous variants in Wnt pathway genes in a child with severe AS highlights a potential polygenic or pathway-level contribution to disease susceptibility, even within a consanguineous context. These findings support a role for Wnt signaling in aortic valve development and pathology, motivating further functional studies and broader cohort analyses to clarify pathogenicity, segregation, and clinical relevance.
KW - Aortic stenosis
KW - Case report
KW - Congenital heart disease
KW - Consanguinity
KW - Polygenic inheritance
KW - Whole-exome sequencing
KW - Wnt signaling pathway
UR - https://www.scopus.com/pages/publications/105019195014
U2 - 10.3389/fcvm.2025.1614666
DO - 10.3389/fcvm.2025.1614666
M3 - Article
AN - SCOPUS:105019195014
SN - 2297-055X
VL - 12
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 1614666
ER -